CALIDAD DE VIDA Y CONTROL DE LA URTICARIA CRÓNICA ESPONTÁNEA EN PACIENTES ATENDIDOS EN UNA INSTITUCIÓN PRIVADA EN RIOBAMBA.

Abstract

Background: Antihistamine treatment is the first choice of treatment for Chronic Spontaneous Urticaria (CSU), a condition of unclear etiology. In Ecuador there are no studies evaluating the impact of this management. The objective was to determine the impact on quality of life of antihistamine treatment in patients with CSU. Methodology: A cross-sectional study was carried out that included, without randomization, 102 consecutive adult patients with a definitive diagnosis of CSU, treated at an institution specializing in the management of allergic diseases in Riobamba-Ecuador, who informedly consented by telephone call to participate in an online survey. in which the validated versions in Spanish of the Urticaria Control Test (UCT) and the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL) were applied. Results: In the UCT, the majority of the patients had no affectation of the quality of life (49%) and a global control in 45%; the total assessment showed high scores in 91.2% of cases. The application of the CU-Q2oL in the dimensions of pruritus showed that it affected 45.1%, with a general evaluation of 28.13%. Conclusions: Treatment of CSU with antihistamines achieves adequate levels of quality of life.